CHRISTOPHER EDMONDSON: Open Payments
NPI 1982221156 · BLUE SPRINGS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 48 payments from 15 companies in 2025. Trend: 2023 $1,303 · 2024 $1,405 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $424 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $176 |
| ABBVIE INC. | 5 | $87 |
| Ardelyx, Inc. | 3 | $53 |
| Boston Scientific Corporation | 1 | $39 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 1 | $25 |
Products named: TREMFYA, ENTYVIO, RINVOQ, IBSRELA, WATCHMAN FLX, VOQUEZNA, DUPIXENT, IQIRVO.
Industry payments across MO — which companies pay providers there.
